Latest
Low ADAMTS13 Activity Associated With Poor Prognosis in Acute Myeloid Leukemia
Cardiovascular Side Effects Common With Proteasome Inhibitors in Multiple Myeloma
Genetic Overlap Between Autoimmune Disease and NHL Not Supported by Genome-Wide Association Study
Cost Burden of Disease Progression High in Multiple Myeloma
Therapy With Sirolimus Could Prevent Graft-Versus-Host Disease After Stem Cell Transplant
VWF High-Molecular-Weight Multimer Deficiency Associated With Neurological Symptoms in TTP
Carbapenem Reduces Tumor Burden in Patients With Cutaneous T-Cell Lymphomas and Bacterial Infection
Ruxolitinib Safe, Effective for Hydroxyurea Intolerant/Resistant Polycythemia Vera
A Patient-Centered Model of Congenital Thrombotic Thrombocytopenic Purpura Symptoms and Effects
Unacceptable Benefit-to-Risk Ratio for Addition of Pembrolizumab to 2 Standard-of-Care Regimens in Multiple Myeloma
Prognostic Model for Patients With Systemic Immunoglobulin Light-Chain Amyloidosis and Renal Involvement
Rituximab With or Without Lenalidomide in First-Line Treatment of Follicular Lymphoma
Featured Content
Real-World Data in the Era of Precision Medicine for Lymphoid Malignancies
The use of real-world data shows promise in guiding the development of management strategies for lymphoid malignancies.
A Tool to Select Candidates for Allogeneic Hematopoietic Cell Transplant in CLL
As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.
Frontline Treatment Strategies and Therapeutic Options for Mantle Cell Lymphoma
In a review article, researchers discussed how to maximize treatment efficacy while minimizing adverse effects for patients with mantle cell lymphoma.
Reducing Transfusion Burden and Addressing Unmet Needs in Beta Thalassemia
Lack of resources and poor awareness of thalassemia can make it difficult for patients with beta thalassemia to receive necessary blood transfusions.
Nurses’ Guide to Managing Symptoms of Myeloproliferative Neoplasms
Oncology nurses discuss the importance of ongoing education on the treatments, symptoms, and available information on MPNs for patients, and oncology nurses.
